Physician profile
Paul Raymond Jeffords
NPI 1033106570
$650,840.72
in general payments reported to CMS, 2019-2025
19 companies · $101K in 2025
The $101K reported for 2025 was more than what 92% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $39K · 2021: $49K · 2022: $20K · 2023: $313K · 2024: $85K · 2025: $101K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $246K · Consulting Fee: $128K · Travel and Lodging: $71K · Royalty Or License: $49K · Food and Beverage: $4,382 · Entertainment: $47.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $245,998.89 |
| Consulting Fee | $127,762.50 |
| Travel and Lodging | $70,752.73 |
| Royalty Or License | $48,743.58 |
| Food and Beverage | $4,382.17 |
| Entertainment | $47.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $263,347.00 | 2019-2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Tigershark M, Stratofuse |
| Arteriocyte Medical Systems, INC. | $246,021.28 | 2023-2024 | Magellan |
| Stryker Corporation | $123,090.00 | 2019-2025 | N/A, Cascadia Interbody System, Es2 Spinal System |
| Surgalign Spine Technologies, INC. | $9,105.07 | 2019-2021 | |
| Globus Medical, INC. | $5,469.92 | 2019-2022 | |
| Mirus, LLC | $1,500.00 | 2019 | |
| Medtronic, INC. | $837.67 | 2021 | |
| Vb Spine LLC | $680.73 | 2025 | Bio4, Lite Bio Delivery System, Vulcan Spinal System |
| Intrinsic Therapeutics | $283.89 | 2025 | Barricaid Acd (Annular Closure Device) |
| Zimmer Biomet Holdings, INC. | $165.00 | 2021 | |
| Baxter Healthcare | $76.46 | 2021-2025 | Floseal |
| Ossdsign USA Incorporated | $56.12 | 2025 | Ossdsign Catalyst |
| Xtant Medical INC | $56.09 | 2024 | |
| Davol INC. | $51.95 | 2025 | Arista |
| Bioventus LLC | $25.18 | 2024 | Bonescalpel & Sonicone (O.R.) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.48 | 2025 | Proclaim |
| Depuy Synthes Sales INC. | $19.27 | 2019 | |
| United Orthopedics LLC | $17.64 | 2024 | |
| Ethicon US, LLC | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Jeffords listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.